Your browser doesn't support javascript.
loading
An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer.
Lim, Elgene; Boyle, Frances; Okera, Meena; Loi, Sherene; Goksu, Sema Sezgin; van Hal, Gertjan; Chapman, Sonya C; Gable, Jonathon Colby; Chen, Yanyun; Price, Gregory L; Hossain, Anwar M; Gainford, M Corona; Ezquerra, Meritxell Bellet.
Afiliação
  • Lim E; Garvan Institute of Medical Research, St. Vincent's Clinical School, University of New South Wales, 370 Victoria Street, Darlinghurst, NSW, Australia. e.lim@garvan.org.au.
  • Boyle F; Mater Hospital, North Sydney, NSW, Australia.
  • Okera M; Adelaide Cancer Centre, Kurralta Park, SA, Australia.
  • Loi S; Peter MacCallum Cancer Centre, Melbourne, VI, Australia.
  • Goksu SS; Akdeniz University Medical Faculty, Antalya, Turkey.
  • van Hal G; Eli Lilly and Company, Utrecht, Netherlands.
  • Chapman SC; Eli Lilly and Company, Windlesham, Surrey, UK.
  • Gable JC; Eli Lilly and Company, Indianapolis, IN, USA.
  • Chen Y; Eli Lilly and Company, Indianapolis, IN, USA.
  • Price GL; Eli Lilly and Company, Indianapolis, IN, USA.
  • Hossain AM; Eli Lilly and Company, Indianapolis, IN, USA.
  • Gainford MC; Eli Lilly and Company, Indianapolis, IN, USA.
  • Ezquerra MB; Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Breast Cancer Res Treat ; 195(3): 275-287, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35915198

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Etiology_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Etiology_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article